Evidence map›Paper›PMID 16941202›Full record

ReviewClinical rheumatology2007

A possible link between Crohn's disease and ankylosing spondylitis via Klebsiella infections.

Alan Ebringer, Taha Rashid, Harmale Tiwana, Clyde Wilson

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical rheumatology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Alterations of the Gut Microbiome in Hypertension.Frontiers in cellular and infection microbiology · 2017
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Enteropathic spondyloarthritis: from diagnosis to treatment.Clinical & developmental immunology · 2013
    Review
  17. Review
  18. Article
  19. Rheumatic manifestations of inflammatory bowel disease.World journal of gastroenterology · 2009
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Alan EbringerSchool of Biomedical and Health Sciences, King's College London, 150 Stamford Street, London, SE1 9NN, UK. alan.ebringer@kcl.ac.uk
Taha Rashid
Harmale Tiwana
Clyde Wilson
King's College London · GBKing Edward Memorial Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crohn's disease (CD) is an immune-mediated gastrointestinal inflammatory disease, which could arise from an interplay between genetic and environmental factors. Klebsiella microbes were suggested to have a vital role in the initiation and perpetuation of the disease through the mechanism of molecular mimicry. This proposition is based on the results of various studies where significantly elevated levels of antibodies against the whole bacteria or preparations from Klebsiella microbes and antibodies to collagen types I, III, IV, and V were detected in patients with CD and patients with ankylosing spondylitis (AS). Molecular similarities were found between Klebsiella nitrogenase and HLA-B27 genetic markers and between Klebsiella pullulanase and collagen fibers types I, III, and IV. Furthermore, significantly positive correlations and cross-reactivity binding activities were observed between anti-Klebsiella and anticollagen antibodies among patients with CD and AS. Early treatment of CD patients with anti-Klebsiella measures is proposed, which may involve the use of antibiotics and low starch diet together with other traditionally used immunomodulatory, immunosuppressive, or biologic agents.

Indexed as

Anti-Bacterial AgentsAntibodies, BacterialAnti-Inflammatory AgentsCrohn DiseaseHumansKlebsiella InfectionsMolecular MimicrySpondylitis, AnkylosingAnti-Bacterial AgentsAntibodies, BacterialAnti-Inflammatory Agents

Identifiers

PMID16941202
OpenAlexW2043662019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.